Inogen (INGN) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.29% |
| Dec 31, 2025 | 0.82% |
| Sep 30, 2025 | 0.27% |
| Jun 30, 2025 | 1.01% |
| Mar 31, 2025 | -2.28% |
| Dec 31, 2024 | -9.20% |
| Sep 30, 2024 | -10.92% |
| Jun 30, 2024 | -17.48% |
| Mar 31, 2024 | -18.17% |
| Dec 31, 2023 | -19.47% |
| Sep 30, 2023 | -26.81% |
| Jun 30, 2023 | -20.36% |
| Mar 31, 2023 | -18.74% |
| Dec 31, 2022 | -17.26% |
| Sep 30, 2022 | -8.44% |
| Jun 30, 2022 | -5.64% |
| Mar 31, 2022 | -0.39% |
| Dec 31, 2021 | 5.99% |
| Sep 30, 2021 | 11.41% |
| Mar 31, 2021 | 3.78% |
| Dec 31, 2020 | 3.24% |
| Sep 30, 2020 | 3.51% |
| Mar 31, 2020 | 18.27% |
| Dec 31, 2019 | 19.01% |
| Sep 30, 2019 | 24.54% |
| Jun 30, 2019 | 21.39% |
| Mar 31, 2019 | 29.45% |
| Dec 31, 2018 | 36.65% |
| Sep 30, 2018 | 32.34% |
| Jun 30, 2018 | 32.40% |
| Mar 31, 2018 | 31.74% |
| Dec 31, 2017 | 28.51% |
| Sep 30, 2017 | 27.70% |
| Jun 30, 2017 | 27.19% |
| Mar 31, 2017 | 25.91% |
| Dec 31, 2016 | 32.69% |
| Sep 30, 2016 | 34.19% |
| Jun 30, 2016 | 25.65% |
| Mar 31, 2016 | 21.77% |
| Dec 31, 2015 | 15.15% |
| Sep 30, 2015 | 14.81% |
| Jun 30, 2015 | 8.07% |
| Mar 31, 2015 | 9.56% |
| Dec 31, 2014 | 70.01% |